Vania Marrone
Vania Marrone has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Silvia Tarentini
Department of Department of Neuroscience, Mental Health and Sense Organs NESMOS, Sapienza University, Rome, Italy
3 shared publications Simonetta Monini
3 shared publications- Chiara Filippi
Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Medicine and Psychology, Otolaryngology Unit, Sapienza University, Rome, Italy
2 shared publications - Edoardo Covelli
Sapienza University of Rome
2 shared publications Luigi Volpini
2 shared publicationsMaurizio Barbara
2 shared publications
Latest Publications
- Open Access
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 13 (2) , 285-288
Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment
Intralabyrinthine schwannoma (ILS) is a rare benign tumor that affects the ends of cochlear and vestibular nerves. In a majority of the cases, it occurs with unilateral progressive sensorineural hearing loss. Less frequent symptoms include tinnitus, imbalance, vertigo, or fullness. The advent of magnetic resonance imaging allows early diagnosis and enables an appropriate therapeutic protocol. This report describes a case of intravestibular schwannoma, with fluctuating hearing loss and intractable vertigo, treated with intratympanic gentamicin. The patient was a 28-year-old woman with intractable vertigo and fluctuating left-side hearing loss caused by left intravestibular schwannoma. Because surgery was temporarily rejected by the patient, a single dose of intratympanic gentamicin was administered. Following this, the patient showed a significant improvement in the symptoms. However, moderate to flat sensorineural hearing loss was also observed. Intratympanic gentamicin infiltration is a valid therapeutic option for patients with ILS, affected by intractable vertigo, when the patient refuses surgery. Cite this article as: Covelli E, Volpini L, Filippi C, Tarantini S, Marrone V, Monini S, et al. Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment. J Int Adv Otol 2017; 13: 285-8.
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 13 (2) , 285-288
Open AccessIntralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment
Intralabyrinthine schwannoma (ILS) is a rare benign tumor that affects the ends of cochlear and vestibular nerves. In a majority of the cases, it occurs with unilateral progressive sensorineural hearing loss. Less frequent symptoms include tinnitus, imbalance, vertigo, or fullness. The advent of magnetic resonance imaging allows early diagnosis and enables an appropriate therapeutic protocol. This report describes a case of intravestibular schwannoma, with fluctuating hearing loss and intractable vertigo, treated with intratympanic gentamicin. The patient was a 28-year-old woman with intractable vertigo and fluctuating left-side hearing loss caused by left intravestibular schwannoma. Because surgery was temporarily rejected by the patient, a single dose of intratympanic gentamicin was administered. Following this, the patient showed a significant improvement in the symptoms. However, moderate to flat sensorineural hearing loss was also observed. Intratympanic gentamicin infiltration is a valid therapeutic option for patients with ILS, affected by intractable vertigo, when the patient refuses surgery. Cite this article as: Covelli E, Volpini L, Filippi C, Tarantini S, Marrone V, Monini S, et al. Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment. J Int Adv Otol 2017; 13: 285-8.
- 18 May 2017
- Published by S. Karger AG in Audiology and Neurotology
- Vol. 22 (1) , 24-29
Delayed Effect of Active Pressure Treatment on Endolymphatic Hydrops
Objective: To identify eventual correlations between the effect of low-pressure treatment and endolymphatic hydrops in Ménière patients. Material and Methods: The study group consisted of subjects affected by definite Ménière disease (2015) and a severe degree of disability, who received a ventilation tube with or without a low-pressure treatment before undergoing a surgical procedure (vestibular neurectomy). After the placement of the ventilation tube, the subjects were either left alone with the tube or received 1 month of self-administered low-pressure therapy with a portable device. In all subjects, an electrocochleography (ECochG) was performed and specific questionnaires - Dizziness Handicap Inventory (DHI) and Functional Scale Level (FSL) - were completed before starting either arm of treatment, at the end of treatment, and then 3 and 6 months later. Results: All selected subjects presented with an ECochG pattern that was indicative of endolymphatic hydrops before starting either treatment. At the end of pressure treatment, 80% showed symptomatic improvement while maintaining the hydropic ECochG pattern. At the 3-month control stage, the hydropic pattern resulted normalized (<0.5) in all the improved subjects. Conclusions: Although 1 month of low-pressure treatment provided a positive symptomatological outcome, normalization of the hydropic ECochG parameters occurred only at a later time. Therefore, it is possible to assume that endolymphatic hydrops could be concurrent with a non-symptomatic stage of Ménière disease, and that the anti-hydropic effect of the low-pressure treatment, if any, would present with a certain delay after its completion.
- 18 May 2017
- Published by S. Karger AG in Audiology and Neurotology
- Vol. 22 (1) , 24-29
Delayed Effect of Active Pressure Treatment on Endolymphatic Hydrops
Objective: To identify eventual correlations between the effect of low-pressure treatment and endolymphatic hydrops in Ménière patients. Material and Methods: The study group consisted of subjects affected by definite Ménière disease (2015) and a severe degree of disability, who received a ventilation tube with or without a low-pressure treatment before undergoing a surgical procedure (vestibular neurectomy). After the placement of the ventilation tube, the subjects were either left alone with the tube or received 1 month of self-administered low-pressure therapy with a portable device. In all subjects, an electrocochleography (ECochG) was performed and specific questionnaires - Dizziness Handicap Inventory (DHI) and Functional Scale Level (FSL) - were completed before starting either arm of treatment, at the end of treatment, and then 3 and 6 months later. Results: All selected subjects presented with an ECochG pattern that was indicative of endolymphatic hydrops before starting either treatment. At the end of pressure treatment, 80% showed symptomatic improvement while maintaining the hydropic ECochG pattern. At the 3-month control stage, the hydropic pattern resulted normalized (<0.5) in all the improved subjects. Conclusions: Although 1 month of low-pressure treatment provided a positive symptomatological outcome, normalization of the hydropic ECochG parameters occurred only at a later time. Therefore, it is possible to assume that endolymphatic hydrops could be concurrent with a non-symptomatic stage of Ménière disease, and that the anti-hydropic effect of the low-pressure treatment, if any, would present with a certain delay after its completion.
- Open Access
- 19 January 2009
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 135 (1) , 22-27
Rapid Maxillary Expansion for the Treatment of Nasal Obstruction in Children Younger Than 12 Years
Rapid maxillary expansion (RME) is an orthodontic and orthopedic procedure currently indicated for the treatment of bilateral crossbite with maxillary constriction. Maxillary constriction is one of the features that characterize the so-called skeletal developmental syndrome, represented by bilateral dental maxillary crossbite, high palatal vault, nasal obstruction derived from elevation of the nasal floor, turbinate hypertrophy, and mouth breathing.1 When the maxillary dental arch is rapidly expanded, maxillary and palatine bones disarticulate along their common midpalatal suture and move laterally so that part of the lateral nasal walls are shifted outward with a small increase of transalar width.
- 19 January 2009
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 135 (1) , 22-27
Open AccessRapid Maxillary Expansion for the Treatment of Nasal Obstruction in Children Younger Than 12 Years
Rapid maxillary expansion (RME) is an orthodontic and orthopedic procedure currently indicated for the treatment of bilateral crossbite with maxillary constriction. Maxillary constriction is one of the features that characterize the so-called skeletal developmental syndrome, represented by bilateral dental maxillary crossbite, high palatal vault, nasal obstruction derived from elevation of the nasal floor, turbinate hypertrophy, and mouth breathing.1 When the maxillary dental arch is rapidly expanded, maxillary and palatine bones disarticulate along their common midpalatal suture and move laterally so that part of the lateral nasal walls are shifted outward with a small increase of transalar width.
- 1 January 2005
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 125 (7) , 693-696
Digital hearing aids for high-frequency sensorineural hearing loss: Preliminary experience with the RetroX® device
Conclusions. The RetroX(R) outer ear hearing aid seems to represent a means of overcoming problems with understanding speech in noise in patients with high-frequency sensorineural hearing loss (SNHL) without the need to wear conventional completely-in-the-canal (CIC) hearing aids, which are usually reported to annoy patients as a result of the occlusion effect. Objective. To present preliminary data from a study carried out to compare the efficacy, in the same individual, of a standard digital CIC hearing aid and a new implantable outer ear canal device, the RetroX. Material and methods. Three out of 15 adults affected by high-frequency SNHL who were candidates for auditory rehabilitation were evaluated by using speech audiometric tests in quiet and noise as well as a questionnaire shortly after use of a CIC hearing aid and the RetroX device, i.e. at 7 and 14 days. The efficacy of the RetroX was anticipated by testing all the subjects using a RetroX simulating system before starting the study protocol. Results. In all three implanted patients, the RetroX provided better audiological benefit for speech understanding in noise. These findings were corroborated by the results of the questionnaire, which showed greater satisfaction with the RetroX, especially regarding the absence of the occlusion effect
- 1 January 2005
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 125 (7) , 693-696
Digital hearing aids for high-frequency sensorineural hearing loss: Preliminary experience with the RetroX® device
Conclusions. The RetroX(R) outer ear hearing aid seems to represent a means of overcoming problems with understanding speech in noise in patients with high-frequency sensorineural hearing loss (SNHL) without the need to wear conventional completely-in-the-canal (CIC) hearing aids, which are usually reported to annoy patients as a result of the occlusion effect. Objective. To present preliminary data from a study carried out to compare the efficacy, in the same individual, of a standard digital CIC hearing aid and a new implantable outer ear canal device, the RetroX. Material and methods. Three out of 15 adults affected by high-frequency SNHL who were candidates for auditory rehabilitation were evaluated by using speech audiometric tests in quiet and noise as well as a questionnaire shortly after use of a CIC hearing aid and the RetroX device, i.e. at 7 and 14 days. The efficacy of the RetroX was anticipated by testing all the subjects using a RetroX simulating system before starting the study protocol. Results. In all three implanted patients, the RetroX provided better audiological benefit for speech understanding in noise. These findings were corroborated by the results of the questionnaire, which showed greater satisfaction with the RetroX, especially regarding the absence of the occlusion effect